Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

被引：0
|
作者：
H Kato
K Yamamoto
Y Oki
S Ine
H Taji
D Chihara
Y Kagami
M Seto
Y Morishima
机构：
[1] Aichi Cancer Center Hospital,Department of Hematology and Cell Therapy
[2] Aichi Cancer Center Research Institute,Division of Molecular Medicine
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：166 / 169
页数：3
相关论文
共 50 条
  • [1] Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas
    Kato, H.
    Yamamoto, K.
    Oki, Y.
    Ine, S.
    Taji, H.
    Chihara, D.
    Kagami, Y.
    Seto, M.
    Morishima, Y.
    LEUKEMIA, 2012, 26 (01) : 166 - 169
  • [2] Erratum: Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas
    H Kato
    K Yamamoto
    Y Oki
    S Ine
    H Taji
    D Chihara
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2013, 27 : 1792 - 1792
  • [3] Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas (vol 26, pg 166, 2012)
    Kato, H.
    Yamamoto, K.
    Oki, Y.
    Ine, S.
    Taji, H.
    Chihara, D.
    Kagami, Y.
    Seto, M.
    Morishima, Y.
    LEUKEMIA, 2013, 27 (08) : 1792 - 1792
  • [4] Clinical value of flow cytometric immunophenotyping analyses for minimal residual disease detection in stem-cell products in patients with follicular and mantle cell lymphoma: comparison to IgH-polymerase chain reaction
    Kato, H.
    Yamamoto, K.
    Oki, Y.
    Chihara, D.
    Ine, S.
    Taji, H.
    Seto, M.
    Kagami, Y.
    Morishima, Y.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S198 - S198
  • [5] Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation
    Takamatsu, H.
    Takezako, N.
    Zheng, J.
    Moorhead, M.
    Carlton, V. E. H.
    Kong, K. A.
    Murata, R.
    Ito, S.
    Miyamoto, T.
    Yokoyama, K.
    Matsue, K.
    Sato, T.
    Kurokawa, T.
    Yagi, H.
    Terasaki, Y.
    Ohata, K.
    Matsumoto, M.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2503 - 2510
  • [6] Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis
    Zhang, Linsheng
    Self, Sally E.
    Lazarchick, John
    BLOOD, 2010, 116 (21) : 793 - 793
  • [7] Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: A retrospective study
    Liu, Hong
    Yuan, Constance
    Heinerich, Jeremy
    Braylan, Raul
    Chang, Myron
    Wingard, John
    Moreb, Jan
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 306 - 314
  • [8] Detection of minimal residual disease in follicular lymphomas using PCR: value of clonospecific probes
    Al Saati, T
    Galoin, S
    Roda, D
    Huynh, A
    Attal, M
    Delsol, G
    BULLETIN DU CANCER, 1998, 85 (10) : 847 - 854
  • [9] Flow Cytometric Immunophenotypic Assessment of T-Cell Clonality by Vβ Repertoire Analysis Detection of T-Cell Clonality at Diagnosis and Monitoring of Minimal Residual Disease Following Therapy
    Tembhare, Prashant
    Yuan, Constance M.
    Xi, Liqiang
    Morris, John C.
    Liewehr, David
    Venzon, David
    Janik, John E.
    Raffeld, Mark
    Stetler-Stevenson, Maryalice
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (06) : 890 - 900
  • [10] Minimal Residual Disease Detection in Mantle Cell Lymphoma: Technical Aspects and Clinical Relevance
    Pott, Christiane
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 172 - 184
12345